Top Cancer Stocks in United States
Browse the largest United States companies in the world ranked by their Market Capitalization. Global Cancer Companies in United States market cap is $120.67B.
23 Nov 2024, 03:42 UTC
Companies: 166
🇺🇸101 |  | $1.63 | -1.21% | 42.95M | -6.32% | Underperform S&P500 YTD Benchamark | 🦾 AI | - |
🇺🇸102 |  | $3.91 | 2.62% | 41.93M | -7.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸103 |  | $1.00 | 0.00% | 40.36M | -65.75% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸104 |  | $4.15 | 0.48% | 39.86M | -49.70% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸105 |  | $1.40 | 1.45% | 39.06M | 20.69% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸106 |  | $0.43 | 2.44% | 37.78M | -90.61% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸107 |  | $1.93 | 2.66% | 37.61M | -12.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸108 |  | $1.42 | 0.00% | 34.98M | -80.28% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸109 |  | $0.90 | -7.49% | 31.59M | -25.84% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸110 |  | $1.96 | -5.77% | 31.29M | 70.43% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸111 |  | $5.86 | -5.02% | 31.02M | -53.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸112 |  | $1.41 | -6.62% | 27.14M | -67.59% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸113 |  | $2.14 | 1.42% | 26.30M | -25.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸114 |  | $1.64 | -1.20% | 26.24M | 257.30% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸115 |  | $0.60 | -0.97% | 25.62M | 11.87% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸116 |  | $0.74 | -1.33% | 25.54M | -30.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸117 |  | $0.55 | -2.86% | 24.98M | -79.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸118 |  | $2.77 | -0.72% | 24.62M | -48.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸119 |  | $2.95 | -5.14% | 24.37M | 14.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸120 |  | $0.62 | -1.29% | 23.61M | -44.96% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸121 |  | $0.30 | 0.33% | 22.20M | -85.46% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇺🇸122 |  | $0.80 | -1.52% | 21.96M | 28.45% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸123 |  | $1.92 | 5.49% | 21.82M | 2.67% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸124 |  | $0.37 | 7.35% | 21.69M | -95.98% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸125 |  | $0.60 | -0.18% | 21.58M | -51.62% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸126 |  | $3.04 | 1.33% | 20.26M | -47.40% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸127 |  | $1.84 | -0.81% | 17.44M | 17.63% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸128 |  | $2.90 | -3.01% | 17.07M | 422.52% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸129 |  | $3.66 | -0.95% | 16.74M | 401.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸130 |  | $0.68 | 4.45% | 15.70M | -72.58% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸131 |  | $0.31 | 3.33% | 15.14M | -29.55% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸132 |  | $0.39 | 0.00% | 15.03M | -2.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸133 |  | $0.69 | -1.99% | 14.71M | -44.52% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸134 |  | $0.33 | 0.00% | 14.27M | -75.91% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸135 |  | $2.85 | 2.15% | 13.92M | -1.38% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸136 |  | $0.08 | 0.00% | 13.76M | -33.33% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇺🇸137 |  | $1.04 | -0.95% | 12.85M | 126.09% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸138 |  | $0.49 | -5.63% | 12.15M | -31.45% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸139 |  | $0.13 | -0.81% | 11.98M | -86.34% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸140 |  | $1.41 | -6.00% | 11.85M | -21.67% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸141 |  | $3.02 | 0.17% | 11.27M | -35.85% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸142 |  | $1.85 | -2.63% | 10.98M | -26.88% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸143 |  | $1.14 | 0.00% | 10.72M | 62.86% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸144 |  | $0.99 | -1.98% | 10.59M | -48.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸145 |  | $0.16 | -3.53% | 10.56M | -92.93% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸146 |  | $0.02 | 0.00% | 7.98M | -50.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸147 |  | $0.15 | -21.05% | 7.81M | 3.45% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇺🇸148 |  | $1.68 | 3.40% | 7.58M | -6.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸149 |  | $1.00 | 0.00% | 7.24M | 66.67% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸150 |  | $1.34 | 2.29% | 7.20M | -65.19% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸151 |  | $1.77 | 3.51% | 6.97M | 167.37% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸152 |  | $0.31 | 1.30% | 6.55M | -57.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸153 |  | $0.05 | 15.96% | 5.51M | -74.17% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸154 |  | $1.00 | 0.00% | 5.25M | 64.61% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸155 |  | $1.65 | 11.49% | 4.88M | -84.72% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸156 |  | $0.25 | -22.76% | 4.80M | 36.31% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸157 |  | $2.00 | -6.54% | 4.50M | -17.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸158 |  | $0.45 | -5.43% | 4.08M | -77.01% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸159 |  | $1.20 | -1.84% | 3.82M | -14.46% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸160 |  | $0.33 | -4.35% | 3.17M | -98.23% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸161 |  | $0.01 | 3.92% | 2.72M | 10.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸162 |  | $1.69 | 0.00% | 2.13M | 70.71% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸163 |  | $0.04 | 0.00% | 1.88M | -33.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸164 |  | $0.04 | -13.95% | 1.09M | 48.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸165 |  | $1.05 | 2.45% | 1.07M | -61.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸166 |  | $1.00 | 1.01% | 1.04M | -42.53% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
